Article

A Phase I/II Study of Adoptive SARS-CoV-2 Specific T Cells in Immunocompromised Hosts with or at Risk of Severe COVID-19 Infection

2023-08-16

Abstract excerpt

Background: Post-transplant or haematological cancer patients have a higher risk of mortality after infection with ancestral and early variants of SARS-CoV-2 . Adoptive cell therapy (ACT) with virus-specific T cells could augment endogenous T cell immunity to avoid disease deterioration before viral clearance.<br><br>Methods: We established a third-party SARS-CoV-2 specific T cell (COVID-T) bank in 2020 (NCT043516...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fc607525-d3d8-5648-a902-a1126d542b54
DOI: 10.2139/ssrn.4540292

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Phase I/II Study of Adoptive SARS-CoV-2 Specific T Cells in Immunocompromised Hosts with or at Risk of Severe COVID-19 InfectionDOI 10.2139/ssrn.4540292Read

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPYSemantic proximity Read

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsSemantic proximity Read

HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era.Semantic proximity Read

A Novel Cell Therapy for COVID-19 and Potential Future Pandemics: Virus Induced Lymphocytes (VIL)Semantic proximity Read

TCR signatures following SARS-CoV-2 infection correlate with clinical symptoms and post-acute sequelae of COVID-19Semantic proximity Read

SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individualsSemantic proximity Read

Immunogenicity of COVID-19 mRNA Vaccines in Immunocompromised Patients: A Systematic Review and Meta-AnalysisSemantic proximity Read

A novel method for identifying SARS-CoV-2 infection mutants via an epitope-specific CD8+ T cell testSemantic proximity Read

Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; A systematic review and meta-analysisSemantic proximity Read

Cancer Therapy and Immunogenicity of COVID Vaccine – CANINE StudySemantic proximity Read

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsSemantic proximity Read

Suboptimal SARS-CoV-2-specific CD8<sup>+</sup> T-cell response associated with the prominent HLA-A*02:01 phenotypeSemantic proximity Read